- Forums
- ASX - By Stock
- OSL
- Ann: Oncosil breakthrough device receives CE Marking approval
Ann: Oncosil breakthrough device receives CE Marking approval, page-19
-
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.18M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 825675 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 510336 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 825675 | 0.008 |
6 | 3607214 | 0.007 |
16 | 13729001 | 0.006 |
28 | 26925008 | 0.005 |
31 | 23853699 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 300336 | 2 |
0.008 | 14596622 | 15 |
0.009 | 17013573 | 10 |
0.010 | 11783000 | 9 |
0.012 | 10910 | 1 |
Last trade - 09.59am 16/07/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online